Neuropathix Inc. (OTCMKTS:NPTX) Stock Extends Rally: Soars 60% in a Week

September 29, 2021

Neuropathix Inc. (OTCMKTS:NPTX) was up 12% and 60% in a week. The company has announced that its wholly-owned subsidiary Kannalife Sciences Inc. has received a notice of award for a $2.97 million grant for Phase 2 STTR Study from the NIH’s National Institute of Neurological Disorders and Stroke. The 3-year STTR Study Grant will be funded via the NIH HEAL Initiative for Development of Therapies and Technologies Directed at Enhanced…